Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xios Therapeutics

Xios Therapeutics
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$1M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of novel small molecule therapeutics capable of preventing tumors from evading the immune system. The company focuses on immuno-oncology pathways and mechanisms that can be best targeted by small molecule therapeutics.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 100 Beaver Street
  • Waltham, MA 02453
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xios Therapeutics’s full profile, request a free trial.

Xios Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 05-Jul-2018 $1M 000 0000 Completed Product Development
1. Early Stage VC (Series A) 31-Dec-2015 000 000 0000 Completed Stealth
To view this company’s complete deal history including valuation and funding, request access »

Xios Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Xios Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Sutter Hill Ventures Venture Capital Minority 000 0000 000000 0

Xios Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Diala Ezzeddine Ph.D Chief Executive Officer, President & Board Member

Xios Therapeutics Board Members (3)

Name Representing Role Since Contact
Info
Diala Ezzeddine Ph.D Xios Therapeutics Chief Executive Officer, President & Board Member 000 0000
Jeff Bird Xios Therapeutics Board Member 000 0000
Richard Wagner Ph.D Self Board Member 000 0000